The slip
PARKINSON RECEIPTno. 11842
27 Oct 2026, 10:49 UTCdopamine neurons, braak
predictionPGM2L1 in dopamine neurons tracks Braak Lewy-body stage
registered5532819f837d5e30
discovery+0.43 p=0.249 n=9
replication+0.58 p=0.104 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.43, p 0.249)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTed736501862e0c8717d73d12…
follows c62a2c77d78e…
Covered by the on-chain checkpoint of receipt 11868 (2026-10-27 11:24 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11842: PGM2L1 in dopamine neurons, braak
- power
- full sample +0.53 (p 0.025, n 18), 95% CI +0.08 to +0.80. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.45 (p 0.059, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.47 (p 0.050, n 18). not the mix.
- skeptic
- leave-one-out range +0.47 to +0.59, sign flips 0; without severely affected donors +0.53 (p 0.025, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PGM2L1 in dopamine neurons.
case closed: nothing better to follow up.